The Oxalate–Microbiome Connection
Oxalate is a small, two-carbon dicarboxylic acid found in many plant foods — spinach, rhubarb, beetroot, almonds, chocolate, and tea are among the highest sources. Roughly 40 to 50 percent of urinary oxalate comes from diet, with the remainder produced endogenously by the liver. Calcium oxalate stones account for approximately 70 to 80 percent of all kidney stones, making oxalate metabolism a clinically significant issue for the 10 to 15 percent of people who develop nephrolithiasis during their lifetime.
In the gut, dietary oxalate can be degraded by specific bacteria — most notably Oxalobacter formigenes, a Gram-negative obligate anaerobe that uses oxalate as its sole carbon and energy source. O. formigenes expresses the enzymes oxalyl-CoA decarboxylase and formyl-CoA transferase, converting oxalate to formate and CO2. It also stimulates colonic oxalate secretion via the anion transporter SLC26A6, effectively pulling oxalate from the blood into the gut lumen for degradation.
Multiple studies have found that individuals colonised with O. formigenes have lower urinary oxalate excretion and a reduced risk of recurrent calcium oxalate stones. Conversely, loss of O. formigenes — which is exquisitely sensitive to many common antibiotics including fluoroquinolones, doxycycline, and metronidazole — increases enteric oxalate absorption and urinary excretion.
Beyond O. formigenes, other bacteria contribute to oxalate degradation: certain Lactobacillus and Bifidobacterium species express oxalate-degrading enzymes, though with lower efficiency. The collective oxalate-degrading capacity of the gut microbiome, rather than any single species, likely determines net oxalate handling.
Enteric Hyperoxaluria
After Roux-en-Y gastric bypass or extensive ileal resection, fat malabsorption leads to calcium binding with fatty acids in the gut lumen, leaving free oxalate available for absorption. This enteric hyperoxaluria dramatically increases kidney stone risk — up to 30 percent of bypass patients develop nephrolithiasis. The combination of fat malabsorption, bile acid diarrhoea, reduced urine volume, and often antibiotic-induced loss of oxalate-degrading bacteria creates a perfect storm.
Dietary Management
The traditional approach to dietary oxalate management focuses on three strategies: reducing high-oxalate food intake, ensuring adequate calcium consumption with meals (calcium binds oxalate in the gut, forming insoluble calcium oxalate that is excreted in faeces rather than absorbed), and maintaining high fluid intake to dilute urinary oxalate concentration. Emerging approaches include probiotic supplementation with O. formigenes or engineered strains, though clinical trial results have been mixed — a phase II/III trial of an O. formigenes preparation showed significant urinary oxalate reduction in patients with primary hyperoxaluria but less consistent results in secondary forms.
The microbiome dimension adds nuance to stone prevention: preserving gut microbial diversity through judicious antibiotic use and adequate dietary fibre may be as important as restricting oxalate-rich foods.